Đorđe Jovanović Transfer from Basel to Čukarički
Serbian centre-forward Đorđe Jovanović, who is 27, has returned to Čukarički on a two-year contract after terminating his agreement with Bazel on the final day of the summer transfer window. The club signed him to replace Fiorin Durmišaj, who is injured. Čukarički had been interested in Jovanović approximately ten days prior, but a deal was not possible while he was still under contract with the Swiss club. The termination of his contract caused the Serbian side to act, bringing back a player who had his most productive career period at the club. This period previously led to his transfer to Maccabi Tel Aviv in 2022 for a fee reported to be €1.9 million. A possible motivation for the transfer is for director Vladimir Matijašević to help the player regain form so he can assist the team and potentially be sold later. The Serbian international has 4 caps for his country and his current market value, according to Transfermarkt, is €650k.
Serbian centre-forward Đorđe Jovanović, who is 27, has returned to Čukarički on a two-year contract after terminating his agreement with Bazel on the final day of the summer transfer window. The club signed him to replace Fiorin Durmišaj, who is injured. Čukarički had been interested in Jovanović approximately ten days prior, but a deal was not possible while he was still under contract with the Swiss club. The termination of his contract caused the Serbian side to act, bringing back a player who had his most productive career period at the club. This period previously led to his transfer to Maccabi Tel Aviv in 2022 for a fee reported to be €1.9 million. A possible motivation for the transfer is for director Vladimir Matijašević to help the player regain form so he can assist the team and potentially be sold later. The Serbian international has 4 caps for his country and his current market value, according to Transfermarkt, is €650k.
Follow rumours and join the conversation.
Follow Rumours
View transfer rumours on our TikTok, Instagram and X.